Calcipotriene ointment 0.005% for psoriasis: A safety and efficacy study
- 1 January 1995
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 32 (1) , 67-72
- https://doi.org/10.1016/0190-9622(95)90186-8
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- High-dose topical calcipotriol in the treatment of extensive psoriasis vulgarisBritish Journal of Dermatology, 1993
- Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgarisJournal of the American Academy of Dermatology, 1992
- Will 1,25-Dihydroxyvitamin D3, MC 903, and Their Analogues Herald a New Pharmacologic Era for the Treatment of Psoriasis?Archives of Dermatology, 1989
- Treatment of Psoriasis by the Topical Application of the Novel Cholecalciferol Analogue Calcipotriol (MC 903)Archives of Dermatology, 1989
- Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind studyBritish Journal of Dermatology, 1988
- Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivoBiochemical Pharmacology, 1988
- An open study of vitamin D3 treatment in psoriasis vulgarisBritish Journal of Dermatology, 1986